Real World Evidence Conference #Part1 - English version
An event organised in the framework of the French Presidency of the Council of the European Union (1).
The Real World Evidence Conference, organized by the ANSM was held on March 8 and 9.
The use of real-world data is a rapidly expanding area in healthcare product development and monitoring due to increased capabilities for massive data collection based on improved computing and digital capabilities.
The recent pandemic has significantly accelerated data sharing, but the impact is much broader...
The Real World Data conference was an opportunity to give voice to European experts, share experiences from different countries and discuss in a roundtable.
(1) This event is not organized by the French Government but is authorized to use the French Presidency of the Council of the European Union logo.
▬▬▬▬▬▬▬▬▬▬▬ SOMMAIRE DE LA VIDEO ▬▬▬▬▬▬▬▬▬▬▬
00:00 Générique
00:00:16 Introduction Christelle Ratignier Carbonneil, Director general, ANSM, France
00:07:56 Reinforced pharmacovigilance of COVID-19 vaccines surveillance in France
00:28:02 The French Regional Pharmacovigilance Network in COVID-19 Vaccines safety monitoring
00:51:00 Questions & Answer
00:56:45 An European pharmacovigilance system in the COVID-19 vaccines surveillance –the Norwegian experience
01:20:28 Questions & Answer
01:28:56 Pharmaco-epidemiology studies
02:16:36 Questions & Answer
02:18:51 Information and transparency
02:24:15 Real World Data in the European decision
02:39:24 Questions & Answer
02:43:35 Conclusion session 1
02:48:00 Introduction session 2
02:51:01 Academia-regulator collaboration in covid-19
03:25:55 Questions & Answer
03:37:31 An Italian Distributed Multi‑Database Healthcare Network:The VALORE Project
04:10:19 Questions & Answer
04:28:20 Generating evidence using an international common data model
04:52:17 Questions & Answer
05:04:04 Enhancing use of real-world evidence for regulatory purposes: DARWIN EU® and the EMA registry initiative
05:36:32 Questions & Answer
05:43:42 Conclusion session 2
#ANSM #BigData #PFUE
The Real World Evidence Conference, organized by the ANSM was held on March 8 and 9.
The use of real-world data is a rapidly expanding area in healthcare product development and monitoring due to increased capabilities for massive data collection based on improved computing and digital capabilities.
The recent pandemic has significantly accelerated data sharing, but the impact is much broader...
The Real World Data conference was an opportunity to give voice to European experts, share experiences from different countries and discuss in a roundtable.
(1) This event is not organized by the French Government but is authorized to use the French Presidency of the Council of the European Union logo.
▬▬▬▬▬▬▬▬▬▬▬ SOMMAIRE DE LA VIDEO ▬▬▬▬▬▬▬▬▬▬▬
00:00 Générique
00:00:16 Introduction Christelle Ratignier Carbonneil, Director general, ANSM, France
00:07:56 Reinforced pharmacovigilance of COVID-19 vaccines surveillance in France
00:28:02 The French Regional Pharmacovigilance Network in COVID-19 Vaccines safety monitoring
00:51:00 Questions & Answer
00:56:45 An European pharmacovigilance system in the COVID-19 vaccines surveillance –the Norwegian experience
01:20:28 Questions & Answer
01:28:56 Pharmaco-epidemiology studies
02:16:36 Questions & Answer
02:18:51 Information and transparency
02:24:15 Real World Data in the European decision
02:39:24 Questions & Answer
02:43:35 Conclusion session 1
02:48:00 Introduction session 2
02:51:01 Academia-regulator collaboration in covid-19
03:25:55 Questions & Answer
03:37:31 An Italian Distributed Multi‑Database Healthcare Network:The VALORE Project
04:10:19 Questions & Answer
04:28:20 Generating evidence using an international common data model
04:52:17 Questions & Answer
05:04:04 Enhancing use of real-world evidence for regulatory purposes: DARWIN EU® and the EMA registry initiative
05:36:32 Questions & Answer
05:43:42 Conclusion session 2
#ANSM #BigData #PFUE